Fonville Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$231K Buy
251
+50
+25% +$50.7K 0.04% 127
2025
Q4
$216K Buy
+201
New +$192K 0.04% 123
2025
Q2
Sell
-309
Closed -$255K 124
2025
Q1
$255K Sell
309
-35
-10% -$29.1K 0.08% 105
2024
Q4
$266K Sell
344
-44
-11% -$36.4K 0.09% 95
2024
Q3
$343K Buy
+388
New +$349K 0.12% 83
2024
Q2
Sell
-305
Closed -$237K 99
2024
Q1
$237K Buy
+305
New +$217K 0.11% 86

Other funds holding LLY

Fonville Wealth Management's LLY Position: Q1 2026 in Review

Fonville Wealth Management increased its Eli Lilly (LLY) stake by 25% in Q1 2026, buying an estimated $50.7K and bringing the position to 251 shares worth $231K. The position accounts for 0.04% of the portfolio, ranked #127.

Fonville Wealth Management first reported a position in LLY in Q1 2024 and has held it in 6 quarters since. The position peaked at $343K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fonville Wealth Management held 251 shares of Eli Lilly worth $231K as of Q1 2026.
  • Fonville Wealth Management bought 50 Eli Lilly shares in Q1 2026, an estimated $50.7K.
  • Eli Lilly made up 0.04% of Fonville Wealth Management's portfolio in Q1 2026, its #127 holding.
  • Fonville Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 6 quarters since.
  • Fonville Wealth Management's Eli Lilly position peaked at $343K in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fonville Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.